Welcome to polybiocept

8%

Our website is under construction.
About our current projects and pipeline projects,
please see the news below.


Current Project (May 2017)
PBMC + eTil Composite T-Cell and TURICs Graft

polybiocept clinically developing an autologus Composite T-Cell and TURICs Graft in several solid cancer indications. The “TURICs” (Tumor Ueber Reactive Immune Cells) Graft is a combination of information from Peripheral Blood Mononuclear Cells (PBMCs) and Tumor Infiltrating Lymphocytes, which has superior properties compared to standalone PBMC or standalone TIL grafts.

polybiocept and our shareholders are conducting discussions with potential strategic and financial partners interested in this exciting project.


to get notified when our website is ready to launch, please register with your e-mail address.